Cargando…
The usage of SGLT-2 inhibitors in the management of heart failure in rural Africa: mitigating the barriers to the optimal adoption of a novel, adjuvant therapeutic agent in the management of heart failure
Autores principales: | Ashinze, Patrick, Abdul-Rahman, Toufik, Wireko, Andrew Awuah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541732/ https://www.ncbi.nlm.nih.gov/pubmed/37772698 http://dx.doi.org/10.1177/17539447231202933 |
Ejemplares similares
-
Lung Metastases to the Heart with Atypical Clinical Manifestations of Cardiac Failure
por: HYRIAVENKO, Nataliia, et al.
Publicado: (2023) -
A reflection of Africa’s cardiac surgery capacity to manage congenital heart defects: a perspective
por: Awuah, Wireko A., et al.
Publicado: (2023) -
Emerging concepts in heart failure management and treatment: focus on SGLT2 inhibitors in heart failure with preserved ejection fraction
por: De Lorenzi, Andrea Beatriz, et al.
Publicado: (2023) -
SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
por: Lam, Carolyn S. P., et al.
Publicado: (2019) -
SGLT2 Inhibitors and Ketone Metabolism in Heart Failure
por: Saucedo-Orozco, Huitzilihuitl, et al.
Publicado: (2022)